MI-463

CAS No. 1628317-18-9

MI-463 ( MI463;MI 463 )

Catalog No. M12428 CAS No. 1628317-18-9

MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 Get Quote
10MG 140 Get Quote
25MG 250 Get Quote
50MG 357 Get Quote
100MG 484 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MI-463
  • Note
    Research use only, not for human use.
  • Brief Description
    MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL.
  • Description
    MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL (IC50=15.3 nM; Kd=9.9 nM); shows profound effects in MLL leukemia cells and substantial survival benefit in mouse models of MLL leukemia.
  • Synonyms
    MI463;MI 463
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1628317-18-9
  • Formula Weight
    484.54
  • Molecular Formula
    C24H23F3N6S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=C2C(NC(C#N)=C2)=CC=C1CN(CC3)CCC3NC4=C(C=C(CC(F)(F)F)S5)C5=NC=N4
  • Chemical Name
    1H-Indole-2-carbonitrile, 4-methyl-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Borkin D, et al. Cancer Cell. 2015 Apr 13;27(4):589-602.
molnova catalog
related products
  • T1551

    T1551 is a novel, potent and specific PRMT5 inhibitor with IC50 of 34.1 uM.

  • EPZ-015866

    EPZ-015866 (GSK-591, GSK-3203591) is a potent, selective protein methyltransferase 5 (PRMT5) inhibitor with IC50 of 4 nM.

  • GSK503

    GSK503 is a potent, specific EZH2 methyltransferase inhibitor that inhibits the methyltransferase activity of WT and mutant EZH2 with similar potency (Ki app=3-27 nM).